A phase I trial of amplimexon (Imexon, Inj.) plus gemcitabine in previously treated inoperable stage III and stage IV non-small cell lung cancer
Phase of Trial: Phase I
Latest Information Update: 20 Jan 2006
At a glance
- Drugs Gemcitabine; Imexon
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 20 Jan 2006 New trial record.